Related Experiment Videos

Adenoviral vector cytotoxicity depends in part on the transgene encoded

C Zheng1, C M Goldsmith, B C O'Connell

  • 1Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland, 20892-1190, USA.

Insights

First-generation adenoviral vectors cause cell death, with cytotoxicity influenced by the encoded transgene. This study demonstrates that the specific transgene impacts adenoviral vector-induced toxicity in epithelial cells.

Area of Science:

  • Gene therapy
  • Molecular biology
  • Cell biology

Background:

  • First-generation adenoviral vectors are known to induce G(2)/M arrest and cell death.
  • The contribution of the encoded transgene to this cytotoxicity has remained unclear.

Purpose of the Study:

  • To investigate whether adenoviral vector cytotoxicity is solely related to the vector or also influenced by the transgene.
  • To compare the cytotoxic effects of vectors with different transgenes at varying multiplicities of infection (m.o.i.).

Main Methods:

  • Epithelial cells were infected with seven adenoviral vectors at low (50) and high (200) m.o.i.
  • Vectors included those with no transgene, cytoplasmic reporter proteins (luciferase, beta-galactosidase), or secretory proteins (alpha1-antitrypsin, growth hormone).
  • Cell cycle progression (G(2)/M arrest) and cell number were measured after 24 hours.

Main Results:

  • Vectors encoding cytoplasmic reporter proteins induced the highest cytotoxicity (35-40% G(2)/M arrest) at a m.o.i. of 50.
  • Vectors without transgenes showed lower cytotoxicity (15-23% G(2)/M arrest).
  • Vectors encoding secretory proteins resulted in intermediate cytotoxicity (22-25% G(2)/M arrest).

Conclusions:

  • Adenoviral vector-induced cytotoxicity is, in part, dependent on the specific transgene being encoded.
  • This finding is crucial for optimizing adenoviral vector design in gene therapy applications.

Related Concept Videos